India county Johnson covid-19 vaccine prevention India county Johnson

Johnson & Johnson seeks nod for trial of Covid vaccine on 12-17 year age group in India

Reading now: 755
www.livemint.com

Johnson & Johnson has submitted an application to the Central Drugs Standard Control Organisation (CDSCO) to conduct a study of its COVID-19 vaccine in India in adolescents aged 12-17 years," news agency ANI tweeted.

Johnson & Johnson has submitted an application to the Central Drugs Standard Control Organisation (CDSCO) to conduct a study of its COVID-19 vaccine in India in adolescents aged 12-17 years.

The single-shot vaccine, developed by J&J shown to be 85 per cent efficacy in preventing severe disease in Phase 3 human clinical trials.

Earlier in August, J&J informed had pplied for Emergency Use Authorization (EUA) of its single-dose COVID-19 vaccine Janssen in India.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA